Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by givmeabrakeon Jan 04, 2014 2:46pm
429 Views
Post# 22058680

Connecting the dots - no conflict here....

Connecting the dots - no conflict here....

 

https://www.dwpv.com/en/Our-Work/Our-Work-Search-Results?Industry=Life-Sciences

 

  •  
  • Acting for Fonds de solidarité des travailleurs du Québec (F.T.Q.) and Caisse de dépôt et placement du Québec in connection with the proposed acquisition by the Permira funds of the shares of Atrium Innovations Inc. by way of plan of arrangement.
     
  • Acting for Joddes Limited and members of the Goodman family, the largest shareholders of Paladin Labs Inc., in connection with the acquisition of Paladin Labs Inc. by Endo Health Solutions Inc. in a stock and cash transaction valued at approximately $1.7 billion.
     
  • Acting for Paladin Labs Inc. in connection with its acquisition by Endo Health Solutions Inc. in a stock and cash transaction valued at approximately $1.7 billion.
     
  • Acted for Paladin Labs Inc. in connection with the acquisition of Bioniche Life Sciences Inc.'s debt facility with Capital Royalty Partners II L.P. and its affiliates for approximately US$22 million, the entering into of an amended loan agreement whereby Paladin Labs Inc. provided an additional US$8-million facility to support Bioniche Life Sciences Inc.'s ongoing operations and the entering into of a licensing agreement for Bioniche Life Sciences Inc.'s bladder cancer product.
     
  • Acted for Paladin Labs Inc. in connection with its acquisition of Allon Therapeutics Inc. The transaction was achieved by way of a proposal to creditors and reorganization of share capital pursuant to the Bankruptcy and Insolvency Act and the Canada Business Corporations Act.
  •  
<< Previous
Bullboard Posts
Next >>